Peptides in gyms: what research says, the risks, and legality in Poland
In gym locker rooms, conversations about peptides are becoming more common. BPC-157 for injuries, ipamorelin for growth hormone, TB-500 for recovery. Social media is full of reports from people claiming peptides transformed their training. As a trainer or studio owner, you need to be ready for client questions. What does science actually say — and where do facts end and risks begin?
What peptides are and why they're trending
Peptides are short chains of amino acids — from 2 to about 50 units. They differ from proteins primarily in size. Your body naturally produces hundreds of peptides that serve hormonal, immune, and regulatory functions. Insulin, oxytocin, vasopressin — these are all peptides.
However, peptides used in gym culture are synthetic analogues of natural peptides, designed in laboratories to produce specific effects: stimulating growth hormone, accelerating tissue healing, or reducing body fat. Their popularity has surged over the past 5 years, driven by fitness influencers, biohacking podcasts, and easy online availability.
The problem is that most peptides sold as sports supplements have not undergone full clinical trials in humans. They're sold as "research chemicals" — meaning they're formally not intended for human consumption.
Popular peptides in gym culture
BPC-157 (Body Protection Compound) is a peptide isolated from human gastric juice. In animal studies, it has shown the ability to accelerate healing of tendons, muscles, ligaments, and bones. It's the most commonly used peptide for sports injuries, typically administered via subcutaneous injection near the injury site.
Ipamorelin is a selective ghrelin receptor agonist (GHS-R) that stimulates growth hormone secretion from the pituitary gland. Compared to other GH secretagogues (like GHRP-6), it produces fewer side effects — it doesn't significantly affect cortisol or prolactin. Used primarily for improved recovery and body fat reduction.
TB-500 (Thymosin Beta-4) is a synthetic version of the naturally occurring thymosin beta-4 peptide. In preclinical studies, it has shown anti-inflammatory and pro-angiogenic properties — supporting new blood vessel formation in damaged tissues. Popular among athletes for post-injury recovery support.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue. It extends pulsatile GH secretion, which is intended to support muscle building and fat burning. Often combined with ipamorelin as a so-called peptide combo.
What scientific research says — the state of knowledge in 2026
This is where the gap between internet narrative and scientific reality begins. Most evidence for peptide effectiveness comes from in vitro (cell) and in vivo animal studies. There are far too few randomized, placebo-controlled clinical trials in humans to formulate clear recommendations.
BPC-157 has impressive results in rats. Sikiric and colleagues have published over 100 papers documenting its regenerative effects in animals. However, by 2026, only a few small Phase I/II clinical trials have been conducted in humans. Their results are promising but insufficient to consider BPC-157 a medication with proven efficacy.
Ipamorelin has a better evidence base. Clinical trials have confirmed its ability to stimulate GH secretion in humans with an acceptable short-term safety profile. However, the long-term effects of chronic use are unknown.
Most evidence for peptide effectiveness comes from animal studies. There are too few randomized clinical trials in humans to formulate clear health recommendations.
The key issue is extrapolating animal results to humans. Rats metabolize substances differently than humans, doses used in animal studies don't translate directly to human doses, and laboratory conditions don't reflect the reality of self-injection at home. That's why enthusiastic rat study reports should be treated as a starting point, not a destination.
Health risks — what influencers don't tell you
Peptides carry several categories of risk that are rarely discussed on social media.
Product quality is probably the biggest threat. Peptides sold online as "research chemicals" are not subject to the quality controls required for medications. An analysis by Cohen et al. (2023) found that up to 68% of peptides purchased online contained incorrect amounts of active substance — too little, too much, or an entirely different compound than declared. Some samples contained heavy metals, bacterial endotoxins, or solvent residues.
Infection risk associated with self-preparation and administration of injections. People using peptides at home often reconstitute lyophilized powder with bacteriostatic water and inject subcutaneously. Without proper sterility, skin infections, abscesses, or in extreme cases, sepsis can occur.
Unknown long-term effects. Growth hormone-stimulating peptides (ipamorelin, CJC-1295, GHRP-6) may affect the hypothalamic-pituitary axis with chronic use. There are theoretical concerns about increased risk of cell proliferation — including potentially cancerous cells — with prolonged GH stimulation. The absence of long-term data means these concerns can neither be confirmed nor ruled out.
Drug interactions are another unexplored area. People taking medications for hypertension, diabetes, or thyroid conditions may experience unpredictable interactions with hormone-modulating peptides.
Legal status in Poland and worldwide
The legal situation around peptides is complex and varies by country. In Poland, peptides such as BPC-157, ipamorelin, and TB-500 are not registered as medications or dietary supplements. This means selling them as products intended for consumption is formally illegal under the Pharmaceutical Law.
In practice, peptides are available in Poland through online stores as "research chemicals." Sellers include disclaimers stating that products are not intended for human consumption. This is a legal grey area — purchasing for research purposes is legal, but self-administration is a different matter.
From a sports perspective — peptides such as ipamorelin, CJC-1295, GHRP-6, and TB-500 are on WADA's prohibited substances list under category S2 (peptide hormones) or S0 (non-approved substances). BPC-157 has also been monitored by WADA since 2024.
In the US, the situation changed in 2023 when the FDA prohibited compounding pharmacies from preparing formulations with certain peptides, including some previously available by prescription.
How to talk to clients about peptides
As a personal trainer or studio owner, you're not a doctor and shouldn't recommend or discourage peptide use in a medical context. You can, however, give your client reliable, fact-based information.
Stay neutral and stick to data. Don't demonize peptides, but don't promote them either. Tell your client: "Animal studies are promising, but solid clinical trials in humans are lacking. We don't know enough about long-term effects." That's an honest position that builds trust.
Emphasize product quality risks. Your client should know that peptides bought online may contain incorrect doses or contaminants. This isn't comparable to buying Creapure-certified creatine.
Always refer to a doctor. If a client is considering peptides, they should consult a sports medicine physician or endocrinologist. Self-dosing hormonally active substances without medical supervision is a risk not worth taking.
Inform about anti-doping consequences. Clients competing in any sporting events — even amateur ones — should know that most peptides are on the WADA list. A positive doping test means disqualification and a potential competition ban.
Redirect attention to proven alternatives. Creatine, caffeine, beta-alanine, vitamin D — these are supplements with solid evidence and safe profiles. For 95% of clients, optimizing diet, sleep, and training will deliver better results than peptides.
Summary
Peptides are a fascinating area of scientific research with potential in regenerative medicine. However, in 2026, there is still insufficient clinical data to consider them safe and effective tools for amateur athletes. Key risks include uncontrolled product quality, lack of long-term data, and ambiguous legal status.
As a trainer, your role isn't to moralize but to provide reliable information. A client who knows what questions to ask a doctor and what risks to consider is a client making informed decisions. And an informed client is a loyal client.
Want to professionally manage client knowledge, their goals, and progress? EloByku gives you the tools to organize that part of your work.
